Cough, Cold and Allergy (hay Fever) Remedies in France

Publication Date	April 2009
Publisher	Euromonitor
Product Type	Report
Pages	54
ISBN Number	not applicable
Product Code	EUR00709

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

PRINT £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Cough, Cold and Allergy Products in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change. Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines Data coverage: market sizes (historic and forecasts), company shares and brand shares Why buy this report? * Get a detailed picture of the cough, cold and allergy (hayfever) industry * Identify factors driving change * Understand the competitive environment, the markets major players and leading brands * Use five-year forecasts to assess how the market is predicted to develop Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

Cough, Cold and Allergy (hay Fever) Remedies in France
Euromonitor International
April 2009
Executive Summary
OTC Healthcare Suffers From Consumers Obtaining More Prescription Products
Increasing Presence of Self-service Areas in Chemists/pharmacies for OTC Products
A Fragmented Market Led by OTC Manufacturers
Chemists/pharmacies Remains the Leading Distribution Channel
Positive Performance Through the Development of Self-medication
Key Trends and Developments
the Setting-up of Self-service: Its Impact on Self-medication
Vitamins and Dietary Supplements for Everyone
the Grey Market Is the New Key Target Consumer Group
Decreasing Purchasing Power Favours Rx Products
Market Indicators
Market Data
$1OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Definitions
Arkopharma Sa, Laboratoires Pharmaceutiques
Strategic Direction
Key Facts
Company Background
Competitive Positioning
Beaufour-ipsen SA
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Cooper SA
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
GlaxoSmithKline Sant Grand Public Sas
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Juva Sant, Laboratoires
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Laboratoires Mcneil
Strategic Direction
Key Facts
Company Background
Competitive Positioning
Pierre Fabre Sa, Laboratoires
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Thraplix SA
Strategic Direction
Key Facts
Company Background
Competitive Positioning
Upsa, Laboratoires
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Urgo, Laboratoires
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
List of Summaries
- Summary 1 Rx-to-OTC Healthcare Switches 2006-2008
- Summary 2 Research Sources
- Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
- Summary 4 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
- Summary 5 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2008
- Summary 6 Beaufour-Ipsen SA: Key Facts
- Summary 7 Beaufour-Ipsen SA: Operational Indicators
- Summary 8 Beaufour-Ipsen SA: Production Statistics 2007
- Summary 9 Beaufour-Ipsen SA: Competitive Position 2008
- Summary 10 Cooper SA: Key Facts
- Summary 11 Cooper SA: Operational Indicators
- Summary 12 Cooper SA: Production Statistics 2007
- Summary 13 Cooper SA: Competitive Position 2008
- Summary 14 GlaxoSmithKline Sant Grand Public SAS: Key Facts
- Summary 15 GlaxoSmithKline Sant Grand Public SAS: Operational Indicators
- Summary 16 GlaxoSmithKline France: Production Statistics 2007
- Summary 17 GlaxoSmithKline Sant Grand Public SAS: Competitive Position 2008
- Summary 18 Laboratoires Juva Sant: Key Facts
- Summary 19 Laboratoires Juva Sant: Operational Indicators
- Summary 20 Laboratoires Juva Sant: Production Statistics 2006
- Summary 21 Laboratoires Juva Sant: Competitive Position 2008
- Summary 22 Laboratoires McNeil: Key Facts
- Summary 23 Laboratoires McNeil: Operational Indicators
- Summary 24 Laboratoires McNeil: Competitive Position 2008
- Summary 25 Laboratoires Pierre Fabre SA: Key Facts
- Summary 26 Laboratoires Pierre Fabre SA: Operational Indicators
- Summary 27 Laboratoires Pierre Fabre SA: Production Statistics 2007
- Summary 28 Laboratoires Pierre Fabre SA: Competitive Position 2008
- Summary 29 Thraplix SA: Key Facts
- Summary 30 Thraplix SA: Competitive Position 2008
- Summary 31 Laboratoires UPSA: Key Facts
- Summary 32 Laboratoires UPSA: Operational Indicators
- Summary 33 UPSA Conseil SAS: Production Statistics 2007
- Summary 34 UPSA Conseil SAS: Competitive Position 2008
- Summary 35 Laboratoires Urgo: Key Facts
- Summary 36 Laboratoires Urgo: Operational Indicators
- Summary 37 Laboratoires Urgo: Competitive Position 2008
List of Tables
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
- Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
- Table 14 Sales of Decongestants by Type: Value 2003-2008
- Table 15 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
- Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
- Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
- Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
- Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
- Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013